Most of the time, urine can be used to test forgonorrhea. However, if you have had oral and/or anal sex, swabs may be used to collect samples from your throat and/or rectum. In some cases, a swab may be used to collect a sample from a man's urethra (urine canal) or a woman's cervix (opening to the womb).
Gonorrhea testing market is expected to witness exponential growth attributed to increasing involvement of multiple sex partners and changing lifestyle would significantly boosted the market for gonorrhea testing. 

Market Analysis and Insights: Global Gonorrhea Testing Market
The global Gonorrhea Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gonorrhea Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gonorrhea Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gonorrhea Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gonorrhea Testing market.

Global Gonorrhea Testing Scope and Market Size
Gonorrhea Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gonorrhea Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Nucleic Acid Amplification (NAA)
Gram Stain
Enzyme-linked immunosorbent assay (ELISA)
Gonorrhea Culture
Rapid test

Segment by Application
Hospitals
Pathology Lab

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
Bayer
Merck
Agilent Technologies
Biomerieux
Danaher
Thermo Fisher Scientific
Abbott
DiaSorin
Bristol-Myers Squibb
F. Hoffmann-La Roche